Kazia Therapeutics Limited (KZIA)

Kazia Therapeutics Statistics

Total Valuation

KZIA has a market cap or net worth of $8.59 million. The enterprise value is $6.78 million.

Market Cap	8.59M
Enterprise Value	6.78M

Important Dates

The next estimated earnings date is Friday, November 14, 2025, before market open.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KZIA has 1.12 million shares outstanding. The number of shares has increased by 54.04% in one year.

Current Share Class	n/a
Shares Outstanding	1.12M
Shares Change (YoY)	+54.04%
Shares Change (QoQ)	+47.84%
Owned by Insiders (%)	12.60%
Owned by Institutions (%)	15.52%
Float	976,962

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.53
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.21

Current Ratio	0.21
Quick Ratio	0.19
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -3,891.64% and return on invested capital (ROIC) is -1,846.11%.

Return on Equity (ROE)	-3,891.64%
Return on Assets (ROA)	-85.55%
Return on Invested Capital (ROIC)	-1,846.11%
Return on Capital Employed (ROCE)	-2,068.30%
Revenue Per Employee	$119,166
Profits Per Employee	-$1.35M
Employee Count	13
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	-167,708
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.50% in the last 52 weeks. The beta is 2.15, so KZIA's price volatility has been higher than the market average.

Beta (5Y)	2.15
52-Week Price Change	-71.50%
50-Day Moving Average	7.46
200-Day Moving Average	6.32
Relative Strength Index (RSI)	57.69
Average Volume (20 Days)	95,008

Short Selling Information

Short Interest	16,881
Short Previous Month	15,790
Short % of Shares Out	1.02%
Short % of Float	n/a
Short Ratio (days to cover)	0.10

Income Statement

In the last 12 months, KZIA had revenue of $1.55 million and -$17.58 million in losses. Loss per share was -$24.67.

Revenue	1.55M
Gross Profit	1.55M
Operating Income	-17.91M
Pretax Income	-17.75M
Net Income	-17.58M
EBITDA	-16.76M
EBIT	-17.91M
Loss Per Share	-$24.67

Balance Sheet

The company has $1.90 million in cash and $87,095 in debt, giving a net cash position of $1.81 million or $1.62 per share.

Cash & Cash Equivalents	1.90M
Total Debt	87,095
Net Cash	1.81M
Net Cash Per Share	$1.62
Equity (Book Value)	-2.36M
Book Value Per Share	-2.44
Working Capital	-8.11M

Cash Flow

Operating Cash Flow	-7.22M
Capital Expenditures	n/a
Free Cash Flow	-7.65M
FCF Per Share	-$6.85

Margins

Gross Margin	100.00%
Operating Margin	-1,156.36%
Pretax Margin	-1,145.67%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KZIA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.04%
Shareholder Yield	-54.04%
Earnings Yield	-204.78%
FCF Yield	-89.13%

Analyst Forecast

The average price target for KZIA is $16.00, which is 108.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	108.33%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	102.42%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 17, 2025. It was a reverse split with a ratio of 1:5.

Last Split Date	Apr 17, 2025
Split Type	Reverse
Split Ratio	1:5

Scores

KZIA has an Altman Z-Score of -15.38 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.38
Piotroski F-Score	1